1. Neurostimulation in
Hypertension Management
Part 2 of 3
1
Patent families were
classified into 3
categories based on
the type of nerve
stimulated to regulate
hypertension
Sympathetic34%
Parasympathetic
16%
Both
50%
Exemplary Patent:
US9884182B2
Exemplary Patent:
US8060197B2
Exemplary Patent:
US9656080B2
2
Patent families were
classified into 7
categories based on
the stimulation
technique used to
regulate hypertension
Ultrasound
10%
Magnetic
8%
Thermal
9%
Cryogenic
9%
Electrical
Light
Other
27%
26%
11%
3
Key players and their
patent family counts
CARDIAC PACEMAKERS MEDTRONIC CATALYST BIOSCIENCES
NYXOAH SA ACTELION CIRCUIT THERAPEUTICS
ST. JUDE MEDICAL CYBERONICS STEALTH BIOTHERAPEUTICS
ELECTROCOR BOSTON SCIENTIFIC AUTONOMIX MEDICAL
0
100
200
300
400
Key Players
FamilyCount
4
Exemplary devices
and systems
Mobius HD®
BackBeat® CNT system eCoin
Baroloop CardioFit system
BarostimNeo
TM
5
Ongoing clinical trials
and
market outlook
Clinical trial
locations
CAGR = 11.7%
16 17 18 19 20 21 22 23 24
0
1
2
3
4
5
6
7
8
9
10
YEAR (2015-2025)
USD(billions)
Source: Grand View Research
2251 Grant Road, Suite B
Los Altos, CA 94024
650-472-0644 • info@maxval.com • maxval.com
MaxVal Group, Inc